The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention.'' The purpose of this draft guidance is to assist sponsors in all phases of development of antiviral drugs for the treatment or prevention of smallpox (variola virus) infection. This draft guidance revises the draft guidance for industry entitled ``Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention'' issued on November 23, 2007.
Document
Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Smallpox (Variola Virus) Infection: Developing Drugs ...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 32136
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Smallpox (Variola Virus) Infection: Developing Drugs for Treatment or Prevention; Draft Guidance for Industry; Availability,” thefederalregister.org (July 11, 2018), https://thefederalregister.org/documents/2018-14749/smallpox-variola-virus-infection-developing-drugs-for-treatment-or-prevention-draft-guidance-for-industry-availability.